viewIofina PLC

Iofina restructures its debt

Iofina said the extension of the debt, along with the removal of the convertibility of the notes, is an important step for the company

One of Iofina's extraction plants
Iofina specialises in the exploration and production of iodine, halogen-based speciality chemical derivatives and produced water

Iofina PLC (LON:IOF), the iodine extraction technology specialist, is to restructure its issued convertible loan notes and has also agreed to restructure the term loan facility provided by Stena Investment.

With the agreement of its convertible loan note holders, Iofina has extended the repayment term of the loan by 13 months to 1 July 2020.

READ: Iofina continues in record-busting form

The convertible element of the notes has been removed and the coupon has been increased from 5% to 7.5%, with the new rate kicking in as from 1 January of this year.

As for the term loan, this has also been extended to 1 July 2020, with the interest rate adjusted to 7.5% from the beginning of this year, rising to 12% on 1 June of this year.

Iofina said debt as at the end of 2018, comprised roughly U$22.37mln of loan notes and US$3.26mln owed to Stena Investment.

Positive for shareholders

Dr Tom Becker, the president and chief executive officer of Iofina said: ''Extending the terms of the notes and facility to 1 July 2020 will allow us to continue upgrading and expanding our plants, which in turn will further boost the level of Iodine production. At the same time, the removal of the debt convertibility is a huge positive for our shareholders. With iodine prices continuing to rise we are well positioned to continue the momentum built over the last few years."

In a note to clients, analysts at ‘house’ broker finnCap commented: “Iofina will incur a higher interest rate as a result and can no longer capitalise interest payments, although this still looks the best outcome that could have been expected and removes a major issue that has been weighing on the shares. In our forecasts we have delayed the assumed IOsorb plant expansions by 6-9 months, which reduces our EBITDA forecasts by 11-12%.”

They added: “This sees our DCF-based price target fall 3% to 34p. Nevertheless, Iofina still offers material upside and strong leverage to improving iodine prices and its continued operational recovery.”

In afternoon trading, shares in Iofina were 1.3% lower at 17.50p.

 -- Adds analyst comment, share price --

Quick facts: Iofina PLC

Price: 21.8 GBX

Market: LSE
Market Cap: £41.83 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Iofina PLC named herein, including the promotion by the Company of Iofina PLC in any Content on the Site, the Company receives from said issuer...



Morning Report: Iofina expecting record year-end production

Headlines from the Proactive UK newsroom. Iofina (LON:IOF) expects the iodine price will continue to rise in 2020 after a 20% rise in 2019. Production of iodine over the year will also likely be a record said the extraction specialist with a fifth plant expected to come onstream in Oklahoma...

on 20/12/19

2 min read